AzTrials
AzTrials

Infantile HemiplegiaRIPHIGEONCT04246788

Intensive Robotic Rehabilitation in Children With Hemiparesia Using GEOSYSTEM

A study testing Intensive robotic rehabilitation and classical physiotherapy in people with Infantile Hemiplegia, run by University Hospital, Clermont-Ferrand at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cerebral palsy is the most frequent motor deficiency in children. Among other, it can leads to spastic diplegia or hemiplegia. Walking abilities is an important skill to the families' point of view in term of independence in curent life. Read more about this study

Who is it for?
Ages 4 to 18 years
Conditions the study is for
Infantile Hemiplegia
What is being tested?
Intensive robotic rehabilitation and classical physiotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteFrance
Study dates
17 Jul 2020to 24 Nov 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Hemiplegic children aged from 4 to 18 years
  • GMFCS (Gross Motor Function Classification System) score between I and III with lower limb involvement.
  • Children must walk alone with or without aid at least 10 meters, must have acquired sitting position, must be able to understand simple orders to follow the rehabilitation program.
  • Free and informed consent of holders of parental authority and of the patient
  • Affiliated to the social security system

Who cannot join

  • No lower limb involvement,
  • spasticity = 4 on the modified Ashworth scale,
  • severe cardiorespiratory disease forbidding the rehabilitation program,
  • orthopedic surgery or botulinic toxin injections in the last 6 months before the beginning of the study.

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Clermont Ferrand

    Clermont-Ferrand, Auvergne, 63000

Other trials in France

About this study

Cerebral palsy is the most frequent motor deficiency in children. Among other, it can leads to spastic diplegia or hemiplegia. Walking abilities is an important skill to the families' point of view in term of independence in curent life. Improving the walking parameters has been the main objective in several studies of rehabilitation. The G-EO system is a last generation robot assisting gait training that can adjust cadence, walk lengh, ankle and hip angles and other walking parameters to movement captation. Its superiority in terms of walking abilities has been demonstrated in adults with stroke sequelae. Only one study was realized in pediatric patients with spastic diplegia with promising results. The investigators hypothesize that intensive robot-assited gait training using the G-EO system in hemiplegic children can improve their walking abilities.

Read the detailed description

Objective :

Primary objective: To evaluate walking velocity with the GRAIL (gait real-time analysis and interactive lab) after intensive robot-assisted gait training using the G-EO system in hemiplegic children.

Secondary objectives :Other parameters that will be evaluate include:

  • Endurance on the 6 minute walking test
  • Joint angles and muscular contraction on the GRAIL
  • Number of steps and travelled distance /24h, cardiac frequency and quality of sleep using actimeter bracelet
  • Motor functions using the GMFM (Gross Motor Function Measure)
  • Spasticity using the modified Ashworth scale
  • The functional independence using the Functional Independence Measure (FIM™) for children,
  • The quality of life using the Patient Global Impression (PGI-I)
  • Muscular strength using the muscular testing cotation scale
  • The musculo-squeletal and adipose composition using the peripherical quantitative computed tomography (pQCT)
  • The cerebral area activation using functional MRI Study Type: Controlled randomized pilote study Number of centres: Monocentric study, University hospital of Clermont-Ferrand

Study procedure:

  • Experimental group: 5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks
  • Control group : 3 sessions per week of 30 minutes of classical physiotherapy during two weeks

Study evaluation:

T0 : before rehabilitation :

  • Actimeter for 24h
  • 6 min walking test
  • GRAIL
  • Modified Ashworth scale
  • FIM for children
  • GMFM
  • Muscular testing scale
  • pQCT
  • fMRI

T1 : one month after rehabilitation :

  • idem T0
  • PGI-I questionnary Principal judgement criteria: Walking velocity Secondary judgement criteria: endurance, joint angles, number of steps and travelled distance per 24h, quality of sleep, cardiac frequency, spasticity, functional independence, motor functions, muscular strength, musculo-squeletal and adipose composition, brain activated areas.

Number of subjects:

  • 20 patients in the experimental group
  • 20 patients in the control group All patients enrolled in the control group will benefit of the GEOsystem rehabilitation at the end of the protocole

Inclusion criteria:

Hemiplegic children aged from 4 to 18 years, with a GMFCS (Gross Motor Function Classification System) score between I and III with lower limb involvement. Children must walk alone with or without aid at least 10 meters, must have acquired sitting position, must be able to understand simple orders to follow the rehabilitation program.

Non inclusion criteria:

No lower limb involvement, spasticity = 4 on the modified Ashworth scale, severe cardiorespiratory disease forbidding the rehabilitation program, orthopedic surgery or botulinic toxin injections in the last 6 months before the beginning of the study.

Study calendar:

  • Starting inclusions: March 2020
  • Experimental procedure: March 2020 to March 2021
  • Data analyses and synthesis: April 2021 to Dember 2021

Statistical analyses Statistical analysis will be performed using Stata 13 software (Stata-Corp, College Station, TX) by an experimented statistician (Bruno Pereira) working in the university hospital of Clermont-Ferrand. A type-I error set at α=0.05 will be considered. Monovariate and multivariate analyses considering age as a covariable will be performed.

Ethical considerations This study has already been presented at the local ethical committee and will be presented in July 2019 at the national " comité de protection des personnes ". Written informed consent from both parents will be collected at the inclusion. This study will be in agreement with the declaration of Helsinki and the current regulations of clinical trials. It will be declared on the internet site "clinicaltrials.gov".

Expected results :

Intensive robot-assisted gait training using the G-EO system may improve the walking abilities in children with infantile hemiplegia and consequently improve their independence and quality of life. Musculo-squeletal parameters and profile of cerebral activated areas involved in praxia may also be modified by this intensive rehabilitation.

Being tested
Intensive robotic rehabilitation, classical physiotherapy
Keywords
Infantile hemiplegia, Cerebral palsy, Intensive robotic rehabilitation
Medical subject headings
Hemiplegia, Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intensive robotic rehabilitationOther

    5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks

  • classical physiotherapyOther

    3 sessions per week of 30 minutes of classical physiotherapy during two weeks

Study groups in NCT04246788
Study groupRoleWhat they receive
Cohort 1 : experimental groupExperimental5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks
Receives: Other: Intensive robotic rehabilitation
Cohort 2 : controle groupActive comparator3 sessions per week of 30 minutes of classical physiotherapy during two weeks
Receives: Other: classical physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gait speed

    gait speed assessed during a gait assessment session using the GRAIL system

    Measured: day 1

  2. Gait speed

    gait speed assessed during a gait assessment session using the GRAIL system

    Measured: day 21

  3. Gait speed

    gait speed assessed during a gait assessment session using the GRAIL system

    Measured: day 51

Secondary outcomes (36)
  1. 6 min. walk test (6-WT)

    endurance evaluation by 6 min. walk test (6-WT)

    Measured: day 1

  2. 6 min. walk test (6-WT)

    endurance evaluation by 6 min. walk test (6-WT)

    Measured: day 21

  3. 6 min. walk test (6-WT)

    endurance evaluation by 6 min. walk test (6-WT)

    Measured: day 51

  4. joint angles

    Joint amplitudes measured during gait assessment with the GRAIL

    Measured: day 1

  5. joint angles

    Joint amplitudes measured during gait assessment with the GRAIL

    Measured: day 21

  6. joint angles

    Joint amplitudes measured during gait assessment with the GRAIL

    Measured: day 51

  7. number of steps per 24h

    Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours

    Measured: day 1

  8. number of steps per 24h

    Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours

    Measured: day 21

  9. number of steps per 24h

    Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours

    Measured: day 51

  10. travelled distance

    distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours

    Measured: day 1

  11. travelled distance

    distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours

    Measured: day 21

  12. travelled distance

    distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours

    Measured: day 51

  13. quality of sleep: wristband actimeter

    quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours

    Measured: day 1

  14. quality of sleep: wristband actimeter

    quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours

    Measured: day 21

  15. quality of sleep: wristband actimeter

    quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours

    Measured: day 51

  16. cardiac frequency

    heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours

    Measured: day 1

  17. cardiac frequency

    heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours

    Measured: day 21

  18. cardiac frequency

    heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours

    Measured: day 51

  19. Evaluation of spasticity

    Evaluation of spasticity by the modified Ashworth scale

    Measured: day 1

  20. Evaluation of spasticity

    Evaluation of spasticity by the modified Ashworth scale

    Measured: day 21

  21. Evaluation of spasticity

    Evaluation of spasticity by the modified Ashworth scale

    Measured: day 51

  22. functional independence

    Overall functional independence assessed with the MIF-Môme autonomy scale

    Measured: day 1

  23. functional independence

    Overall functional independence assessed with the MIF-Môme autonomy scale

    Measured: day 21

  24. functional independence

    Overall functional independence assessed with the MIF-Môme autonomy scale

    Measured: day 51

  25. motor functions

    Overall motor function evaluated with the EMFG

    Measured: day 1

  26. motor functions

    Overall motor function evaluated with the EMFG

    Measured: day 21

  27. motor functions

    Overall motor function evaluated with the EMFG

    Measured: day 51

  28. muscular strength

    Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing

    Measured: day 1

  29. muscular strength

    Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing

    Measured: day 21

  30. muscular strength

    Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing

    Measured: day 51

  31. Body composition measurements

    fat body mass

    Measured: day 21

  32. Body composition measurements

    fat body mass

    Measured: day 51

  33. Body composition measurements

    lean body mass

    Measured: day 21

  34. Body composition measurements

    lean body mass

    Measured: day 51

  35. brain activated areas

    Functional brain connectivity analyzes by functional brain MRI

    Measured: day 21

  36. brain activated areas

    Functional brain connectivity analyzes by functional brain MRI

    Measured: day 51

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2020
  2. Study start17 Jul 2020
  3. Primary completion24 Nov 2021
  4. Study completion24 Nov 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04246788
Sponsor's protocol ID
RBHP 2019 SARRET
Other IDs
2019-A02218-49
Acronym
RIPHIGEO
Status last verified
Aug 2026
First submitted
24 Jan 2020
Last updated
6 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Julien L, Moreau-Pernet G, Rochette E, Lemaire JJ, Pontier B, Bourrand S, Pereira B, Chassain C, Sontheimer A, Sarret C. Robot-assisted gait training improves walking and cerebral connectivity in children with unilateral cerebral palsy. Pediatr Res. 2024 Oct;96(5):1306-1315. doi: 10.1038/s41390-024-03240-1. Epub 2024 May 20.

    PubMed 38769400

Questions about this trial

What is this clinical trial studying?

A study testing Intensive robotic rehabilitation and classical physiotherapy in people with Infantile Hemiplegia, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gait speed (time frame: day 1). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04246788, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in